CytomX Therapeutics(CH:6C1)
CH:6C1
CytomX Therapeutics earnings date
CytomX Therapeutics (6C1) Q2 2023 Earnings Report
0 Followers
CH:6C1 Q2 2023 EPS Results
- Actual EPS
- -CHF 0.02
- Consensus EPS
- -CHF 0.16
- Beat/Miss
- Beat by +CHF 0.14
- One Year Ago EPS
- -CHF 0.31
CH:6C1 Q2 2023 Revenue Results
- Actual Revenue
- CHF 20.58M
- Expected Revenue
- CHF 11.39M
- Beat/Miss
- Beat by +CHF 9.19M
- YoY Revenue Growth
- +36.11%
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/08/2023
- Time
- After Close
- Conference Call
- Tuesday, August 8, 2023
CH:6C1 Upcoming Earnings
CytomX Therapeutics's next earnings date is estimated for February 24, 2027, based on past reporting schedules.
Q2 2023 Earnings Call Audio
CH:6C1 Q2 2023 Earnings Call
0:00 / 0:00
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:6C1 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 24, 2027 | 2026 (Q4) | -0.07- | -0.14 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | -0.06-0.07 | -0.07 | 0.00% (+0.00) | |
| Aug 06, 2026 | 2026 (Q2) | -0.06-0.07 | 0 | ― | |
| May 07, 2026 | 2026 (Q1) | -0.10-0.08 | 0.22 | -137.04% (-0.31) | |
| Mar 16, 2026 | 2025 (Q4) | -0.08-0.14 | 0.18 | -178.64% (-0.33) | |
| Nov 06, 2025 | 2025 (Q3) | -0.04-0.07 | 0.06 | -228.57% (-0.13) | |
| Aug 07, 2025 | 2025 (Q2) | -0.050.00 | -0.07 | 100.00% (+0.07) | |
| May 12, 2025 | 2025 (Q1) | 0.100.22 | 0.14 | 58.82% (+0.08) | |
| Mar 06, 2025 | 2024 (Q4) | -0.160.18 | 0.02 | 1000.00% (+0.17) | |
| Nov 07, 2024 | 2024 (Q3) | -0.140.06 | 0.03 | 75.00% (+0.02) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
